Kaposi's sarcoma in human T-cell leukemia virus type I-associated adult
T-cell leukemia
SJ Greenberg, ES Jaffe, GD Ehrlich, NJ Korman, BJ Poiesz and TA Waldmann
Metabolism Branch, National Cancer Institute, National Institutes of
Health, Bethesda, MD 20892.
Kaposi's sarcoma (KS) developed in a patient with human T-cell leukemia
virus type I (HTLV-I)-associated adult T-cell leukemia who was treated with
a short-term course of monoclonal antibody immunotherapy. The presentation
was transient and temporally related to the underlying clinical course. The
association of KS in an HTLV-I infected, but not human immunodeficiency
virus (HIV)-infected, individual should alert investigators to the
occurrence of KS in retroviral-associated diseases other than acquired
immunodeficiency disease syndrome. Recognition of the similarities and
differences between HTLV-I and HIV infections may provide insights
concerning the angiopathogenesis of KS.
Volume 76,
Issue 5,
pp. 971-976,
09/01/1990
Copyright © 1990 by The American Society of Hematology